NATERA, INC. Accounts Receivable, Allowance for Credit Loss, Recovery
NATERA, INC. (NTRA) reported Accounts Receivable, Allowance for Credit Loss, Recovery of $380.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-05.
Discontinued › Notes › Accounts, Notes, Loans and Financing Receivable, Gross, Allowance, and Net
us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries · last filed 2021-11-05
- NATERA, INC. accounts receivable, allowance for credit loss, recovery for the quarter ending 2021-09-30 was $317.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Recovery 3 month | Accounts Receivable, Allowance for Credit Loss, Recovery 6 month | Accounts Receivable, Allowance for Credit Loss, Recovery 9 month |
|---|---|---|---|
| 2021-09-30 | $317.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $380.00K 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $63.00K 10-Q · filed 2021-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |